Screener
10x Genomics, Inc. TXG Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies (Note 5) | ||
| Stockholders’ equity: | ||
| Preferred stock | — | — |
| Common stock | 2 | 2 |
| Additional paid-in capital | 2,367,459 | 2,306,690 |
| Accumulated deficit | (1,541,992) | (1,510,591) |
| Accumulated other comprehensive income | 77 | 225 |
| Total stockholders’ equity | 825,546 | 796,326 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s common stock?
- 10x Genomics, Inc. (TXG) reported common stock of $2K in Q2 2026.
- How has 10x Genomics, Inc.'s common stock changed year-over-year?
- 10x Genomics, Inc.'s common stock decreased by 0.0% year-over-year, from $2K to $2K.
- What is the long-term trend for 10x Genomics, Inc.'s common stock?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s common stock has grown at a 0.0% compound annual growth rate (CAGR), from $2K to $2K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about 10x Genomics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude